What is the required minimum interval between Spravato (esketamine) treatment doses?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Spravato Dosing Intervals

Spravato (esketamine) nasal spray requires a 5-minute rest period between use of each device during a single treatment session, and treatment sessions are scheduled at specific intervals depending on the treatment phase.

Intervals Between Devices Within a Single Session

During each treatment session, there must be a 5-minute rest between use of each nasal spray device 1. For a 56 mg dose, you use 2 devices with a 5-minute break between them. For an 84 mg dose, you use 3 devices with 5-minute breaks between each device.

Intervals Between Treatment Sessions

The dosing frequency varies by treatment phase and indication:

For Treatment-Resistant Depression (TRD)

Induction Phase (Weeks 1-4):

  • Administer twice per week 1, 2

Maintenance Phase (Weeks 5-8):

  • Administer once weekly 1

Extended Maintenance (Week 9 and beyond):

  • Administer every 2 weeks OR once weekly based on individual response 1
  • The dosing frequency should be individualized to the least frequent schedule that maintains remission/response 1

For Major Depressive Disorder with Acute Suicidal Ideation or Behavior

  • Administer 84 mg twice per week for 4 weeks 1, 3
  • Treatment beyond 4 weeks has not been systematically evaluated for this indication 1

Managing Missed Sessions

If a patient misses treatment sessions and depression symptoms have NOT worsened: Continue the current dosing schedule 1

If a patient misses sessions during maintenance treatment and depression symptoms HAVE worsened: Consider returning to the previous more frequent dosing schedule (e.g., if doses were missed during weekly dosing, revert to twice-weekly dosing) 1

Clinical Context

The flexibility in maintenance dosing reflects evidence showing that treatment frequency adjustments based on symptom response optimize outcomes. In the SUSTAIN-2 analysis, when patients transitioned from weekly to every-other-week dosing, 19% further improved, 49% maintained benefit, and 32% worsened. Importantly, when frequency was increased back to weekly for those who worsened, 47% improved again 4. This supports the protocol's built-in flexibility to adjust dosing intervals based on clinical response rather than rigid scheduling.

Critical safety requirement: Each treatment session requires at least 2 hours of post-administration observation under direct healthcare provider supervision before the patient can be discharged 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.